✦ LIBER ✦

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms

✍ Scribed by Tefferi, A; Pardanani, A; Lasho, T L; Finke, C M; Mai, M; McClure, R F

Book ID: 109887408
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 409 KB
Volume: 24
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2010.77

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations of IDH1 and IDH2 genes in earl

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

✍ Kosmider, O; Gelsi-Boyer, V; Slama, L; Dreyfus, F; Beyne-Rauzy, O; Quesnel, B; H 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 223 KB

LNK mutation studies in blast-phase myel

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

✍ Pardanani, A; Lasho, T; Finke, C; Oh, S T; Gotlib, J; Tefferi, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 350 KB

Analysis of IDH1 and IDH2 mutations in J

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients

✍ Yukihiko Sonoda; Toshihiro Kumabe; Taigen Nakamura; Ryuta Saito; Masayuki Kanamo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

IDH1 and IDH2 mutation studies in 1473 p

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

✍ Tefferi, A; Lasho, T L; Abdel-Wahab, O; Guglielmelli, P; Patel, J; Caramazza, D; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 460 KB

IDH1 and IDH2 mutations are rare in pedi

IDH1 and IDH2 mutations are rare in pediatric myeloid malignancies

✍ Oki, K; Takita, J; Hiwatari, M; Nishimura, R; Sanada, M; Okubo, J; Adachi, M; So 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 318 KB

IDH1 and IDH2 hotspot mutations are not

IDH1 and IDH2 hotspot mutations are not found in canine glioma

✍ Zachary J. Reitman; Natasha J. Olby; Christopher L. Mariani; Rachael Thomas; Mat 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB

With great interest, we read the recent publication ''CD44positive cells are responsible for gemcitabine resistance in pancreatic cancer cells'' by Hong et al. 1 In this study, the authors established gemcitabine-resistant pancreatic cancer cells in vitro and characterized them in various ways, in v